Skip to search formSkip to main contentSkip to account menu

2 ML polidocanol 5 MG/ML Injection

Known as: POLIDOCANOL 0.5% INJ,2ML [VA Product], polidocanol 10 MG in 2 ML Injection, polidocanol 0.5 % Injection 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Bronchopleural fistula (BPF) represents a pathological communication between any part of bronchial tree and the pleural space… 
2015
2015
The Polidocanol microfoam sclerotherapy is a potential treatment of venous disease. Recently, four years conducted clinical… 
2014
2014
Raynaud’s phenomenon and skin sclerosis are the most common and prominent characteristics in patients with SSc, but recent data… 
2006
2006
Endochondral calcification involves the participation of matrix vesicles (MVs), but it remains unclear whether calcification… 
2006
2006
OBJECTIVES To determine whether in patients with posterolateral thigh perforator (PLTP) varicosities ultrasound-guided… 
1988
1988
Ein wesentlicher Fortschritt auf dem Gebiet der Therapie gastrointestinaler Blutungen beruht auf den Moglichkeiten der…